Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative Cardiology

Heart Lung and Circulation

Volumn 17, Issue 5, 2008, Pages 411-413

  Bates, Timothy R ^a   Burnett, John R ^a,b   Bockxmeer, Frank M van ^b,c   Hamilton, Sandra ^a,d   Arnolda, Leonard ^a,d   Watts, Gerald F ^a,d  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Familial hypercholesterolaemia; Premature coronary artery disease; Underdetection

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SYMPTOM;

AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 50249097669     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.06.005     Document Type: Article

References (7)

1. Marks D., Thorogood M., Neil A., and Humphries S. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 168 (2003) 1-14
2. Neil H., Hammond T., Huxley R., Matthews D., and Humphries S. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ 321 (2000) 148
3. Eurospire II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22 (2001) 554-572
4. Vale M., Jelinek M., Best J., and for the COACH study group. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust 176 (2002) 211-215
5. Dorsch M., Lawrance R., Durham N., and Hall A. Familial hypercholesterolaemia is underdiagnosed after AMI. BMJ 322 (2001) 111
6. Hamilton-Craig I. Case-finding for familial hypercholesterolemia in the Asia-Pacific region. Semin Vasc Med 4 (2004) 87-92
7. Marks D., Wonderling D., Thorogood M., Lambert H., and Humphries S. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 324 (2002) 1-6